Evidence map›Paper›PMID 39045028›Full record

ArticleMolecular therapy. Oncology2024

Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling.

Nickolas J Serniuck, Eden Kapcan, Duane Moogk, Allyson E Moore, Benjamin P M Lake, Galina Denisova, Joanne A Hammill, Jonathan L Bramson, Anthony F Rullo

Abstract read
In one paragraph

Article in Molecular therapy. Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Lysine Targeting Group-Transfer Chimeras for Proximity Induction.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Antibody Conjugation to Cell Surface Receptors.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Small-molecule control of CAR T cells.Nature reviews. Chemistry · 2025
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nickolas J SerniuckCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Eden KapcanCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Duane MoogkCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Allyson E MooreCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Benjamin P M LakeCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Galina DenisovaMcMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada.
Joanne A HammillCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Jonathan L BramsonCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.
Anthony F RulloCentre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proximity-induction of cell-cell interactions via small molecules represents an emerging field in basic and translational sciences. Covalent anchoring of these small molecules represents a useful chemical strategy to enforce proximity; however, it remains largely unexplored for driving cell-cell interactions. In immunotherapeutic applications, bifunctional small molecules are attractive tools for inducing proximity between immune effector cells like T cells and tumor cells to induce tumoricidal function. We describe a two-component system composed of electrophilic bifunctional small molecules and paired synthetic antigen receptors (SARs) that elicit T cell activation. The molecules, termed covalent immune recruiters (CIRs), were designed to affinity label and covalently engage SARs. We evaluated the utility of CIRs to direct anti-tumor function of human T cells engineered with three biologically distinct classes of SAR. Irrespective of the electrophilic chemistry, tumor-targeting moiety, or SAR design, CIRs outperformed equivalent non-covalent bifunctional adapters, establishing a key role for covalency in maximizing functionality. We determined that covalent linkage enforced early T cell activation events in a manner that was dependent upon each SARs biology and signaling threshold. These results provide a platform to optimize universal SAR-T cell functionality and more broadly reveal new insights into how covalent adapters modulate cell-cell proximity-induction.

Indexed as

chemical/synthetic immunotherapycovalent bifunctional adaptersengineered T cellsMT: Regular Issueproximity induced labelinguniversal synthetic antigen receptors

Identifiers

PMID39045028
PMCPMC11264187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.